Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
Scope of the Report:
This report focuses on the Flu Vaccine in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
CSL
GSK
Sanofi Pasteur
Mylan
AstraZeneca
Pfizer
Johnson & Johnson
Market Segment by Regions, regional analysis covers
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Columbia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Whole Virus Vaccines
Split Virus Vaccines
Subunit Vaccines
Live Attenuated Virus Vaccines
Market Segment by Applications, can be divided into
For Children (6 months to 3 years)
For Adults and Children over 3 years
There are 15 Chapters to deeply display the global Flu Vaccine market.
Chapter 1, to describe Flu Vaccine Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Flu Vaccine, with sales, revenue, and price of Flu Vaccine, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Flu Vaccine, for each region, from 2012 to 2017;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;
Chapter 12, Flu Vaccine market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;
Chapter 13, 14 and 15, to describe Flu Vaccine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Table of Contents
1 Market Overview
1.1 Flu Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Whole Virus Vaccines
1.2.2 Split Virus Vaccines
1.2.3 Subunit Vaccines
1.2.4 Live Attenuated Virus Vaccines
1.3 Market Analysis by Applications
1.3.1 For Children (6 months to 3 years)
1.3.2 For Adults and Children over 3 years
1.4 Market Analysis by Regions
1.4.1 North America (USA, Canada and Mexico)
1.4.1.1 USA Market States and Outlook (2012-2022)
1.4.1.2 Canada Market States and Outlook (2012-2022)
1.4.1.3 Mexico Market States and Outlook (2012-2022)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2012-2022)
1.4.2.2 France Market States and Outlook (2012-2022)
1.4.2.3 UK Market States and Outlook (2012-2022)
1.4.2.4 Russia Market States and Outlook (2012-2022)
1.4.2.5 Italy Market States and Outlook (2012-2022)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2012-2022)
1.4.3.2 Japan Market States and Outlook (2012-2022)
1.4.3.3 Korea Market States and Outlook (2012-2022)
1.4.3.4 India Market States and Outlook (2012-2022)
1.4.3.5 Southeast Asia Market States and Outlook (2012-2022)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2012-2022)
1.4.4.2 Egypt Market States and Outlook (2012-2022)
1.4.4.3 Saudi Arabia Market States and Outlook (2012-2022)
1.4.4.4 South Africa Market States and Outlook (2012-2022)
1.4.4.5 Nigeria Market States and Outlook (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 CSL
2.1.1 Business Overview
2.1.1.1 CSL Flu Vaccine Description
2.1.1.2 CSL Flu Vaccine Headquarter, Main Business and Finance Overview
2.1.2 CSL Flu Vaccine Product Introduction
2.1.2.1 Production Bases, Sales Regions and Major Competitors
2.1.2.2 CSL Flu Vaccine Product Introduction
2.1.3 CSL Flu Vaccine Sales, Revenue and Market Share
2.1.3.1 CSL Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 CSL Flu Vaccine Market Share in Global in 2016
2.2 GSK
2.2.1 Business Overview
2.2.1.1 GSK Flu Vaccine Description
2.2.1.2 GSK Flu Vaccine Headquarter, Main Business and Finance Overview
2.2.2 CSL Flu Vaccine Product Introduction
2.2.2.1 Production Bases, Sales Regions and Major Competitors
2.2.2.2 GSK Flu Vaccine Product Introduction
2.2.3 GSK Flu Vaccine Sales, Revenue and Market Share
2.2.3.1 GSK Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 GSK Flu Vaccine Market Share in Global in 2016
2.3 Sanofi Pasteur
2.3.1 Business Overview
2.3.1.1 Sanofi Pasteur Flu Vaccine Description
2.3.1.2 Sanofi Pasteur Flu Vaccine Headquarter, Main Business and Finance Overview
2.3.2 Sanofi Pasteur Flu Vaccine Product Introduction
2.3.2.1 Production Bases, Sales Regions and Major Competitors
2.3.2.2 Sanofi Pasteur Flu Vaccine Product Introduction
2.3.3 Sanofi Pasteur Flu Vaccine Sales, Revenue and Market Share
2.3.3.1 Sanofi Pasteur Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Sanofi Pasteur Flu Vaccine Market Share in Global in 2016
2.4 Mylan
2.4.1 Business Overview
2.4.1.1 Mylan Flu Vaccine Description
2.4.1.2 Mylan Flu Vaccine Headquarter, Main Business and Finance Overview
2.4.2 Mylan Flu Vaccine Product Introduction
2.4.2.1 Production Bases, Sales Regions and Major Competitors
2.4.2.2 Mylan Flu Vaccine Product Introduction
2.4.3 Mylan Flu Vaccine Sales, Revenue and Market Share
2.4.3.1 Mylan Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Mylan Flu Vaccine Market Share in Global in 2016
2.5 AstraZeneca
2.5.1 Business Overview
2.5.1.1 AstraZeneca Flu Vaccine Description
2.5.1.2 AstraZeneca Flu Vaccine Headquarter, Main Business and Finance Overview
2.5.2 AstraZeneca Flu Vaccine Product Introduction
2.5.2.1 Production Bases, Sales Regions and Major Competitors
2.5.2.2 AstraZeneca Flu Vaccine Product Introduction
2.5.3 AstraZeneca Flu Vaccine Sales, Revenue and Market Share
2.5.3.1 AstraZeneca Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 AstraZeneca Flu Vaccine Market Share in Global in 2016
2.6 Pfizer
2.6.1 Business Overview
2.6.1.1 Pfizer Flu Vaccine Description
2.6.1.2 Pfizer Flu Vaccine Headquarter, Main Business and Finance Overview
2.6.2 Pfizer Flu Vaccine Product Introduction
2.6.2.1 Production Bases, Sales Regions and Major Competitors
2.6.2.2 Pfizer Flu Vaccine Product Introduction
2.6.3 Pfizer Flu Vaccine Sales, Revenue and Market Share
2.6.3.1 Pfizer Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Pfizer Flu Vaccine Market Share in Global in 2016
2.7 Johnson & Johnson
2.7.1 Business Overview
2.7.1.1 Johnson & Johnson Flu Vaccine Description
2.7.1.2 Johnson & Johnson Flu Vaccine Headquarter, Main Business and Finance Overview
2.7.2 Johnson & Johnson Flu Vaccine Product Introduction
2.7.2.1 Production Bases, Sales Regions and Major Competitors
2.7.2.2 Johnson & Johnson Flu Vaccine Product Introduction
2.7.3 Johnson & Johnson Flu Vaccine Sales, Revenue and Market Share
2.7.3.1 Johnson & Johnson Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Johnson & Johnson Flu Vaccine Market Share in Global in 2016
3 Global Flu Vaccine Market Competition, by Manufacturer
3.1 Global Flu Vaccine Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Flu Vaccine Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Flu Vaccine Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Flu Vaccine Manufacturer Market Share
3.4.2 Top 5 Flu Vaccine Manufacturer Market Share
3.5 Market Competition Trend
4 Global Flu Vaccine Market Analysis by Regions
4.1 Global Flu Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Flu Vaccine Sales by Regions (2012-2017)
4.1.2 Global Flu Vaccine Revenue by Regions (2012-2017)
4.2 North America Flu Vaccine Sales and Growth (2012-2017)
4.3 Europe Flu Vaccine Sales and Growth (2012-2017)
4.4 Asia-Pacific Flu Vaccine Sales and Growth (2012-2017)
4.5 South America Flu Vaccine Sales and Growth (2012-2017)
4.6 Middle East and Africa Flu Vaccine Sales and Growth (2012-2017)
5 North America Flu Vaccine by Countries, Type, Application and Manufacturers
5.1 North America Flu Vaccine Sales, Revenue and Market Share by Countries
5.1.1 North America Flu Vaccine Sales by Countries (2012-2017)
5.1.2 North America Flu Vaccine Revenue by Countries (2012-2017)
5.1.3 USA Flu Vaccine Sales and Growth (2012-2017)
5.1.4 Canada Flu Vaccine Sales and Growth (2012-2017)
5.1.5 Mexico Flu Vaccine Sales and Growth (2012-2017)
5.2 North America Flu Vaccine Sales and Revenue (value) by Manufacturers (2016-2017)
5.2.1 North America Flu Vaccine Sales by Manufacturers (2016-2017)
5.2.2 North America Flu Vaccine Revenue by Manufacturers (2016-2017)
5.3 North America Flu Vaccine Sales by Type (2012-2017)
5.4 North America Flu Vaccine Sales by Application (2012-2017)
6 Europe Flu Vaccine by Countries, Type, Application and Manufacturers
6.1 Europe Flu Vaccine Sales, Revenue and Market Share by Countries
6.1.1 Europe Flu Vaccine Sales by Countries (2012-2017)
6.1.2 Europe Flu Vaccine Revenue by Countries (2012-2017)
6.1.3 Germany Flu Vaccine Sales and Growth (2012-2017)
6.1.4 UK Flu Vaccine Sales and Growth (2012-2017)
6.1.5 France Flu Vaccine Sales and Growth (2012-2017)
6.1.6 Russia Flu Vaccine Sales and Growth (2012-2017)
6.1.7 Italy Flu Vaccine Sales and Growth (2012-2017)
6.2 Europe Flu Vaccine Sales and Revenue (value) by Manufacturers (2016-2017)
6.2.1 Europe Flu Vaccine Sales by Manufacturers (2016-2017)
6.2.2 Europe Flu Vaccine Revenue by Manufacturers (2016-2017)
6.3 Europe Flu Vaccine Sales by Type (2012-2017)
6.4 Europe Flu Vaccine Sales by Application (2012-2017)
7 Asia-Pacific Flu Vaccine by Countries, Type, Application and Manufacturers
7.1 Asia-Pacific Flu Vaccine Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Flu Vaccine Sales by Countries (2012-2017)
7.1.2 Asia-Pacific Flu Vaccine Revenue by Countries (2012-2017)
7.1.3 China Flu Vaccine Sales and Growth (2012-2017)
7.1.4 Japan Flu Vaccine Sales and Growth (2012-2017)
7.1.5 Korea Flu Vaccine Sales and Growth (2012-2017)
7.1.6 India Flu Vaccine Sales and Growth (2012-2017)
7.1.7 Southeast Asia Flu Vaccine Sales and Growth (2012-2017)
7.2 Asia-Pacific Flu Vaccine Sales and Revenue (value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Flu Vaccine Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Flu Vaccine Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Flu Vaccine Sales by Type (2012-2017)
7.4 Asia-Pacific Flu Vaccine Sales by Application (2012-2017)
8 South America Flu Vaccine by Countries, Type, Application and Manufacturers
8.1 South America Flu Vaccine Sales, Revenue and Market Share by Countries
8.1.1 South America Flu Vaccine Sales by Countries (2012-2017)
8.1.2 South America Flu Vaccine Revenue by Countries (2012-2017)
8.1.3 Brazil Flu Vaccine Sales and Growth (2012-2017)
8.1.4 Argentina Flu Vaccine Sales and Growth (2012-2017)
8.1.5 Columbia Flu Vaccine Sales and Growth (2012-2017)
8.2 South America Flu Vaccine Sales and Revenue (value) by Manufacturers (2016-2017)
8.2.1 South America Flu Vaccine Sales by Manufacturers (2016-2017)
8.2.2 South America Flu Vaccine Revenue by Manufacturers (2016-2017)
8.3 South America Flu Vaccine Sales by Type (2012-2017)
8.4 South America Flu Vaccine Sales by Application (2012-2017)
9 Middle East and Africa Flu Vaccine by Countries, Type, Application and Manufacturers
9.1 Middle East and Africa Flu Vaccine Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Flu Vaccine Sales by Countries (2012-2017)
9.1.2 Middle East and Africa Flu Vaccine Revenue by Countries (2012-2017)
9.1.3 Saudi Arabia Flu Vaccine Sales and Growth (2012-2017)
9.1.4 UAE Flu Vaccine Sales and Growth (2012-2017)
9.1.5 Egypt Flu Vaccine Sales and Growth (2012-2017)
9.1.6 Nigeria Flu Vaccine Sales and Growth (2012-2017)
9.1.7 South Africa Flu Vaccine Sales and Growth (2012-2017)
9.2 Middle East and Africa Flu Vaccine Sales and Revenue (value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Flu Vaccine Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Flu Vaccine Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Flu Vaccine Sales by Type (2012-2017)
9.4 Middle East and Africa Flu Vaccine Sales by Application (2012-2017)
10 Global Flu Vaccine Market Segment by Type
10.1 Global Flu Vaccine Sales, Revenue and Market Share by Type (2012-2017)
10.1.1 Global Flu Vaccine Sales and Market Share by Type (2012-2017)
10.1.2 Global Flu Vaccine Revenue and Market Share by Type (2012-2017)
10.2 Whole Virus Vaccines Sales Growth and Price
10.2.1 Global Whole Virus Vaccines Sales Growth (2012-2017)
10.2.2 Global Whole Virus Vaccines Price (2012-2017)
10.3 Split Virus Vaccines Sales Growth and Price
10.3.1 Global Split Virus Vaccines Sales Growth (2012-2017)
10.3.2 Global Split Virus Vaccines Price (2012-2017)
10.4 Subunit Vaccines Sales Growth and Price
10.4.1 Global Subunit Vaccines Sales Growth (2012-2017)
10.4.2 Global Subunit Vaccines Price (2012-2017)
10.5 Live Attenuated Virus Vaccines Sales Growth and Price
10.5.1 Global Live Attenuated Virus Vaccines Sales Growth (2012-2017)
10.5.2 Global Live Attenuated Virus Vaccines Price (2012-2017)
11 Global Flu Vaccine Market Segment by Application
11.1 Global Flu Vaccine Sales Market Share by Application (2012-2017)
11.2 For Children (6 months to 3 years) Sales Growth (2012-2017)
11.3 For Adults and Children over 3 years Sales Growth (2012-2017)
12 Flu Vaccine Market Forecast (2017-2022)
12.1 Global Flu Vaccine Sales, Revenue and Growth Rate (2017-2022)
12.2 Flu Vaccine Market Forecast by Regions (2017-2022)
12.2.1 North America Flu Vaccine Market Forecast (2017-2022)
12.2.2 Europe Flu Vaccine Market Forecast (2017-2022)
12.2.3 Asia-Pacific Flu Vaccine Market Forecast (2017-2022)
12.2.4 South America Flu Vaccine Market Forecast (2017-2022)
12.2.5 Middle East and Africa Flu Vaccine Market Forecast (2017-2022)
12.3 Flu Vaccine Market Forecast by Type (2017-2022)
12.4 Flu Vaccine Market Forecast by Application (2017-2022)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source
List of Tables and Figures
Figure Flu Vaccine Picture
Table Product Specifications of Flu Vaccine
Figure Global Sales Market Share of Flu Vaccine by Types in 2016
Table Flu Vaccine Types for Major Manufacturers
Figure Whole Virus Vaccines Picture
Figure Split Virus Vaccines Picture
Figure Subunit Vaccines Picture
Figure Live Attenuated Virus Vaccines Picture
Table Flu Vaccine Sales Market Share by Applications in 2016
Figure For Children (6 months to 3 years) Picture
Figure For Adults and Children over 3 years Picture
Figure USA Flu Vaccine Revenue (Value) and Growth Rate (2012-2022)
Figure Canada Flu Vaccine Revenue (Value) and Growth Rate (2012-2022)
Figure Mexico Flu Vaccine Revenue (Value) and Growth Rate (2012-2022)
Figure Germany Flu Vaccine Revenue (Value) and Growth Rate (2012-2022)
Figure France Flu Vaccine Revenue (Value) and Growth Rate (2012-2022)
Figure UK Flu Vaccine Revenue (Value) and Growth Rate (2012-2022)
Figure Russia Flu Vaccine Revenue (Value) and Growth Rate (2012-2022)
Figure Italy Flu Vaccine Revenue (Value) and Growth Rate (2012-2022)
Figure China Flu Vaccine Revenue (Value) and Growth Rate (2012-2022)
Figure Japan Flu Vaccine Revenue (Value) and Growth Rate (2012-2022)
Figure Korea Flu Vaccine Revenue (Value) and Growth Rate (2012-2022)
Figure India Flu Vaccine Revenue (Value) and Growth Rate (2012-2022)
Figure Southeast Asia Flu Vaccine Revenue (Value) and Growth Rate (2012-2022)
Figure Brazil Flu Vaccine Revenue (Value) and Growth Rate (2012-2022)
Figure Egypt Flu Vaccine Revenue (Value) and Growth Rate (2012-2022)
Figure Saudi Arabia Flu Vaccine Revenue (Value) and Growth Rate (2012-2022)
Figure South Africa Flu Vaccine Revenue (Value) and Growth Rate (2012-2022)
Figure Nigeria Flu Vaccine Revenue (Value) and Growth Rate (2012-2022)
Table CSL Headquarter, Established, Main Business and Finance Overview (2016)
Table CSL Flu Vaccine Production Bases, Sales Regions and Major Competitors
Table CSL Flu Vaccine Product
Table CSL Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table CSL Flu Vaccine Sales Market Share in Global in 2016
Table CSL Flu Vaccine Revenue Market Share in Global in 2016
Table GSK Headquarter, Established, Main Business and Finance Overview (2016)
Table GSK Flu Vaccine Production Bases, Sales Regions and Major Competitors
Table GSK Flu Vaccine Product
Table GSK Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table GSK Flu Vaccine Sales Market Share in Global in 2016
Table GSK Flu Vaccine Revenue Market Share in Global in 2016
Table Sanofi Pasteur Headquarter, Established, Main Business and Finance Overview (2016)
Table Sanofi Pasteur Flu Vaccine Production Bases, Sales Regions and Major Competitors
Table Sanofi Pasteur Flu Vaccine Product
Table Sanofi Pasteur Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi Pasteur Flu Vaccine Sales Market Share in Global in 2016
Table Sanofi Pasteur Flu Vaccine Revenue Market Share in Global in 2016
Table Mylan Headquarter, Established, Main Business and Finance Overview (2016)
Table Mylan Flu Vaccine Production Bases, Sales Regions and Major Competitors
Table Mylan Flu Vaccine Product
Table Mylan Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Mylan Flu Vaccine Sales Market Share in Global in 2016
Table Mylan Flu Vaccine Revenue Market Share in Global in 2016
Table AstraZeneca Headquarter, Established, Main Business and Finance Overview (2016)
Table AstraZeneca Flu Vaccine Production Bases, Sales Regions and Major Competitors
Table AstraZeneca Flu Vaccine Product
Table AstraZeneca Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table AstraZeneca Flu Vaccine Sales Market Share in Global in 2016
Table AstraZeneca Flu Vaccine Revenue Market Share in Global in 2016
Table Pfizer Headquarter, Established, Main Business and Finance Overview (2016)
Table Pfizer Flu Vaccine Production Bases, Sales Regions and Major Competitors
Table Pfizer Flu Vaccine Product
Table Pfizer Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Flu Vaccine Sales Market Share in Global in 2016
Table Pfizer Flu Vaccine Revenue Market Share in Global in 2016
Table Johnson & Johnson Headquarter, Established, Main Business and Finance Overview (2016)
Table Johnson & Johnson Flu Vaccine Production Bases, Sales Regions and Major Competitors
Table Johnson & Johnson Flu Vaccine Product
Table Johnson & Johnson Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Johnson & Johnson Flu Vaccine Sales Market Share in Global in 2016
Table Johnson & Johnson Flu Vaccine Revenue Market Share in Global in 2016
Table Global Flu Vaccine Sales by Manufacturer (2016-2017)
Figure Global Flu Vaccine Sales Market Share by Manufacturer in 2016
Figure Global Flu Vaccine Sales Market Share by Manufacturer in 2017
Table Global Flu Vaccine Revenue by Manufacturer (2016-2017)
Figure Global Flu Vaccine Revenue Market Share by Manufacturer in 2016
Figure Global Flu Vaccine Revenue Market Share by Manufacturer in 2017
Table Global Flu Vaccine Price by Manufacturer (2016-2017)
Figure Global Flu Vaccine Sales and Growth (2012-2017)
Figure Global Flu Vaccine Revenue and Growth (2012-2017)
Table Global Flu Vaccine Sales by Regions (2012-2017)
Table Global Flu Vaccine Sales Market Share by Regions (2012-2017)
Table Global Flu Vaccine Revenue by Regions (2012-2017)
Figure Global Flu Vaccine Revenue Market Share by Regions in 2012
Figure Global Flu Vaccine Revenue Market Share by Regions in 2016
Figure North America Flu Vaccine Sales and Growth (2012-2017)
Figure Europe Flu Vaccine Sales and Growth (2012-2017)
Figure Asia-Pacific Flu Vaccine Sales and Growth (2012-2017)
Figure South America Flu Vaccine Sales and Growth (2012-2017)
Figure Middle East and Africa Flu Vaccine Sales and Growth (2012-2017)
Figure North America Flu Vaccine Revenue and Growth (2012-2017)
Table North America Flu Vaccine Sales by Countries (2012-2017)
Table North America Flu Vaccine Sales Market Share by Countries (2012-2017)
Figure North America Flu Vaccine Sales Market Share by Countries in 2012
Figure North America Flu Vaccine Sales Market Share by Countries in 2016
Table North America Flu Vaccine Revenue by Countries (2012-2017)
Table North America Flu Vaccine Revenue Market Share by Countries (2012-2017)
Figure North America Flu Vaccine Revenue Market Share by Countries in 2012
Figure North America Flu Vaccine Revenue Market Share by Countries in 2016
Figure USA Flu Vaccine Sales and Growth (2012-2017)
Figure Canada Flu Vaccine Sales and Growth (2012-2017)
Figure Mexico Flu Vaccine Sales and Growth (2012-2017)
Table North America Flu Vaccine Sales by Manufacturer (2016-2017)
Figure North America Flu Vaccine Sales Market Share by Manufacturer in 2016
Figure North America Flu Vaccine Sales Market Share by Manufacturer in 2017
Table North America Flu Vaccine Revenue by Manufacturer (2016-2017)
Figure North America Flu Vaccine Revenue Market Share by Manufacturer in 2016
Figure North America Flu Vaccine Revenue Market Share by Manufacturer in 2017
Table North America Flu Vaccine Sales by Type (2012-2017)
Table North America Flu Vaccine Sales Share by Type (2012-2017)
Table North America Flu Vaccine Sales by Application (2012-2017)
Table North America Flu Vaccine Sales Share by Application (2012-2017)
Figure Europe Flu Vaccine Revenue and Growth (2012-2017)
Table Europe Flu Vaccine Sales by Countries (2012-2017)
Table Europe Flu Vaccine Sales Market Share by Countries (2012-2017)
Table Europe Flu Vaccine Revenue by Countries (2012-2017)
Table Europe Flu Vaccine Revenue Market Share by Countries in 2012
Table Europe Flu Vaccine Revenue Market Share by Countries in 2016
Figure Germany Flu Vaccine Sales and Growth (2012-2017)
Figure UK Flu Vaccine Sales and Growth (2012-2017)
Figure France Flu Vaccine Sales and Growth (2012-2017)
Figure Russia Flu Vaccine Sales and Growth (2012-2017)
Figure Italy Flu Vaccine Sales and Growth (2012-2017)
Table Europe Flu Vaccine Sales by Manufacturer (2016-2017)
Figure Europe Flu Vaccine Sales Market Share by Manufacturer in 2016
Figure Europe Flu Vaccine Sales Market Share by Manufacturer in 2017
Table Europe Flu Vaccine Revenue by Manufacturer (2016-2017)
Figure Europe Flu Vaccine Revenue Market Share by Manufacturer in 2016
Figure Europe Flu Vaccine Revenue Market Share by Manufacturer in 2017
Table Europe Flu Vaccine Sales by Type (2012-2017)
Table Europe Flu Vaccine Sales Share by Type (2012-2017)
Table Europe Flu Vaccine Sales by Application (2012-2017)
Table Europe Flu Vaccine Sales Share by Application (2012-2017)
Figure Asia-Pacific Flu Vaccine Revenue and Growth (2012-2017)
Table Asia-Pacific Flu Vaccine Sales by Countries (2012-2017)
Table Asia-Pacific Flu Vaccine Sales Market Share by Countries (2012-2017)
Table Asia-Pacific Flu Vaccine Sales Market Share by Countries (2012-2017)
Table Asia-Pacific Flu Vaccine Revenue by Countries (2012-2017)
Table Asia-Pacific Flu Vaccine Revenue Market Share by Countries (2012-2017)
Figure China Flu Vaccine Sales and Growth (2012-2017)
Figure Japan Flu Vaccine Sales and Growth (2012-2017)
Figure Korea Flu Vaccine Sales and Growth (2012-2017)
Figure India Flu Vaccine Sales and Growth (2012-2017)
Figure Southeast Asia Flu Vaccine Sales and Growth (2012-2017)
Table Asia-Pacific Flu Vaccine Sales by Manufacturer (2016-2017)
Figure Asia-Pacific Flu Vaccine Sales Market Share by Manufacturer in 2016
Figure Asia-Pacific Flu Vaccine Sales Market Share by Manufacturer in 2017
Table Asia-Pacific Flu Vaccine Revenue by Manufacturer (2016-2017)
Figure Asia-Pacific Flu Vaccine Revenue Market Share by Manufacturer in 2016
Figure Asia-Pacific Flu Vaccine Revenue Market Share by Manufacturer in 2017
Table Asia-Pacific Flu Vaccine Sales by Type (2012-2017)
Table Asia-Pacific Flu Vaccine Sales Share by Type (2012-2017)
Table Asia-Pacific Flu Vaccine Sales by Application (2012-2017)
Table Asia-Pacific Flu Vaccine Sales Share by Application (2012-2017)
Figure South America Flu Vaccine Revenue and Growth (2012-2017)
Table South America Flu Vaccine Sales by Countries (2012-2017)
Table South America Flu Vaccine Sales Market Share by Countries (2012-2017)
Figure South America Flu Vaccine Sales Market Share by Countries in 2016
Table South America Flu Vaccine Revenue by Countries (2012-2017)
Table South America Flu Vaccine Revenue Market Share by Countries (2012-2017)
Figure South America Flu Vaccine Revenue Market Share by Countries in 2016
Figure South America Flu Vaccine Revenue Market Share by Countries in 2017
Figure Brazil Flu Vaccine Sales and Growth (2012-2017)
Figure Argentina Flu Vaccine Sales and Growth (2012-2017)
Figure Columbia Flu Vaccine Sales and Growth (2012-2017)
Table South America Flu Vaccine Sales by Manufacturer (2016-2017)
Figure South America Flu Vaccine Sales Market Share by Manufacturer in 2016
Figure South America Flu Vaccine Sales Market Share by Manufacturer in 2017
Table South America Flu Vaccine Revenue by Manufacturer (2016-2017)
Figure South America Flu Vaccine Revenue Market Share by Manufacturer in 2016
Figure South America Flu Vaccine Revenue Market Share by Manufacturer in 2017
Table South America Flu Vaccine Sales by Type (2012-2017)
Table South America Flu Vaccine Sales Share by Type (2012-2017)
Table South America Flu Vaccine Sales by Application (2012-2017)
Table South America Flu Vaccine Sales Share by Application (2012-2017)
Figure Middle East and Africa Flu Vaccine Revenue and Growth (2012-2017)
Table Middle East and Africa Flu Vaccine Sales by Countries (2012-2017)
Table Middle East and Africa Flu Vaccine Sales Market Share by Countries (2012-2017)
Figure Middle East and Africa Flu Vaccine Sales Market Share by Countries in 2016
Table Middle East and Africa Flu Vaccine Revenue by Countries (2012-2017)
Table Middle East and Africa Flu Vaccine Revenue Market Share by Countries (2012-2017)
Figure Middle East and Africa Flu Vaccine Revenue Market Share by Countries in 2012
Figure Middle East and Africa Flu Vaccine Revenue Market Share by Countries in 2016
Figure Saudi Arabia Flu Vaccine Sales and Growth (2012-2017)
Figure UAE Flu Vaccine Sales and Growth (2012-2017)
Figure Egypt Flu Vaccine Sales and Growth (2012-2017)
Figure Nigeria Flu Vaccine Sales and Growth (2012-2017)
Figure South Africa Flu Vaccine Sales and Growth (2012-2017)
Table Middle East and Africa Flu Vaccine Sales by Manufacturer (2016-2017)
Figure Middle East and Africa Flu Vaccine Sales Market Share by Manufacturer in 2016
Figure Middle East and Africa Flu Vaccine Sales Market Share by Manufacturer in 2017
Table Middle East and Africa Flu Vaccine Revenue by Manufacturer (2016-2017)
Figure Middle East and Africa Flu Vaccine Revenue Market Share by Manufacturer in 2016
Figure Middle East and Africa Flu Vaccine Revenue Market Share by Manufacturer in 2017
Table Middle East and Africa Flu Vaccine Sales by Type (2012-2017)
Table Middle East and Africa Flu Vaccine Sales Share by Type (2012-2017)
Table Middle East and Africa Flu Vaccine Sales by Application (2012-2017)
Table Middle East and Africa Flu Vaccine Sales Share by Application (2012-2017)
Table Global Flu Vaccine Sales by Type (2012-2017)
Table Global Flu Vaccine Sales Share by Type (2012-2017)
Table Global Flu Vaccine Revenue by Type (2012-2017)
Table Global Flu Vaccine Revenue Share by Type (2012-2017)
Figure Global Whole Virus Vaccines Sales Growth (2012-2017)
Figure Global Whole Virus Vaccines Price (2012-2017)
Figure Global Split Virus Vaccines Sales Growth (2012-2017)
Figure Global Split Virus Vaccines Price (2012-2017)
Figure Global Subunit Vaccines Sales Growth (2012-2017)
Figure Global Subunit Vaccines Price (2012-2017)
Figure Global Live Attenuated Virus Vaccines Sales Growth (2012-2017)
Figure Global Live Attenuated Virus Vaccines Price (2012-2017)
Table Global Flu Vaccine Sales by Application (2012-2017)
Table Global Flu Vaccine Sales Share by Application (2012-2017)
Figure Global For Children (6 months to 3 years) Sales Growth (2012-2017)
Figure Global For Adults and Children over 3 years Sales Growth (2012-2017)
Figure Global Flu Vaccine Sales, Revenue and Growth Rate (2017 -2022)
Table Global Flu Vaccine Sales Forecast by Regions (2017-2022)
Table Global Flu Vaccine Market Share Forecast by Regions (2017-2022)
Figure North America Sales Flu Vaccine Market Forecast (2017-2022)
Figure Europe Sales Flu Vaccine Market Forecast (2017-2022)
Figure Asia-Pacific Sales Flu Vaccine Market Forecast (2017-2022)
Figure South America Sales Flu Vaccine Market Forecast (2017-2022)
Figure Middle East and Africa Sales Flu Vaccine Market Forecast (2017-2022)
Table Global Flu Vaccine Sales Forecast by Type (2017-2022)
Table Global Flu Vaccine Market Share Forecast by Type (2017-2022)
Table Global Flu Vaccine Sales Forecast by Application (2017-2022)
Table Global Flu Vaccine Market Share Forecast by Application (2017-2022)
Table Distributors/Traders/ Dealers List
